MBX Biosciences, Inc.
MBX
$8.70
$0.070.81%
| 09/30/2024 | 06/30/2024 | 09/30/2023 | |||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 401.36% | -21.41% | -- | ||
| Total Receivables | 423.17% | -17.59% | -- | ||
| Inventory | -- | -- | -- | ||
| Prepaid Expenses | -23.05% | 55.56% | -- | ||
| Finance Division Loans and Leases Current | -- | -- | -- | ||
| Total Finance Division Other Current Assets | -- | -- | -- | ||
| Other Current Assets | 246.28% | 44.05% | -- | ||
| Total Current Assets | 378.17% | -19.11% | -- | ||
|
|
|||||
| Total Current Assets | 378.17% | -19.11% | -- | ||
| Net Property, Plant & Equipment | -7.74% | 45.34% | -- | ||
| Long-term Investments | -- | -- | -- | ||
| Goodwill | -- | -- | -- | ||
| Total Other Intangibles | -- | -- | -- | ||
| Finance Div Loans & Leases LT | -- | -- | -- | ||
| Total Finance Div Other LT Assets | -- | -- | -- | ||
| Total Other Assets | -98.22% | 60.76% | -- | ||
| Total Assets | 349.10% | -16.51% | -- | ||
|
|
|||||
| Total Accounts Payable | 55.29% | 0.78% | -- | ||
| Total Accrued Expenses | 19.46% | 105.51% | -- | ||
| Short-term Debt | -- | -- | -- | ||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | ||
| Finance Division Debt Current | 2.47% | 3.18% | -- | ||
| Total Finance Division Other Current Liabilities | -- | -- | -- | ||
| Total Other Current Liabilities | -- | -- | -- | ||
| Total Current Liabilities | 33.20% | 43.93% | -- | ||
|
|
|||||
| Total Current Liabilities | 33.20% | 43.93% | -- | ||
| Long-Term Debt | -- | -- | -- | ||
| Short-term Debt | -- | -- | -- | ||
| Capital Leases | -49.43% | -32.56% | -- | ||
| Finance Division Debt Non Current | -- | -- | -- | ||
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | ||
| Total Other Liabilities | -45.60% | -32.43% | -- | ||
| Total Liabilities | 31.18% | 39.93% | -- | ||
|
|
|||||
| Common Stock & APIC | 6,556.19% | 21.14% | -- | ||
| Retained Earnings | -17.48% | -18.04% | -- | ||
| Treasury Stock & Other | 806.67% | -400.00% | -- | ||
| Total Common Equity | 377.23% | -17.87% | -- | ||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | ||
| Preferred Stock Non Redeemable | -- | -- | -- | ||
| Preferred Stock Convertible | -- | 0.00% | -- | ||
| Preferred Stock, Others | -- | -- | -- | ||
| Total Preferred Equity | -- | 0.00% | -- | ||
|
|
|||||
| Total Common Equity | 377.23% | -17.87% | -- | ||
| Total Preferred Equity | -- | 0.00% | -- | ||
| Total Minority Interest | -- | -- | -- | ||
| Total Equity | 398.18% | -21.41% | -- | ||
|
|
|||||
